HHS supports development of investigational Ebola treatment
by Press Release from Outbreak News Today on (#4QW13)
An investigational treatment for Ebola virus disease will receive advanced development support from the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR). ASPR's Biomedical Advanced Research and Development Authority (BARDA) will provide $14 million and expertise to Ridgeback Biotherapeutics of Miami to manufacture the therapeutic, mAb114, ["]
The post HHS supports development of investigational Ebola treatment appeared first on Outbreak News Today.